A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies

NCT01607372 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma and Rhinitis

Interventions

DRUG: GSK2245035
DEVICE: Type 1 amber glass bottle
OTHER: Placebo

Sponsor

GlaxoSmithKline

Collaborators

[object Object]